Figure S6 from A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy

Autor: Elizabeth R. Plimack, Peter A. Jones, Kerry S. Campbell, Hui Shen, Stephen B. Baylin, Michael J. Topper, Jean-Pierre J. Issa, David I. Quinn, Noah M. Hahn, Jozef Madzo, Woonbok Chung, Peter W. Nichols, Pooja Ghatalia, Matthew R. Zibelman, Daniel M. Geynisman, Rutika Kokate, Candice L. Schwebel, R. Katherine Alpaugh, Mahvish Tafseer, Ryan S. Burgos, Justin R. Kulchycki, Toshinori Hinoue, Eric A. Ross, Zachary Madaj, Alexander W. Macfarlane, Galen Hostetter, H. Josh Jang
Rok vydání: 2023
DOI: 10.1158/1078-0432.22587048.v1
Popis: Supplementary Figure 6: Gene Set Enrichment Analysis reveals immune-related pathways discriminate PD and SD tumors.
Databáze: OpenAIRE